Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Jan;27(1):139–144. doi: 10.1128/jcm.27.1.139-144.1989

Detection by enzyme-linked immunosorbent assay of specific immunoglobulin G isotypes in primary and established cytomegalovirus infections.

L Joassin 1, A Somze 1, M Reginster 1
PMCID: PMC267249  PMID: 2536385

Abstract

An enzyme-linked immunosorbent assay using monoclonal antibodies was developed to study the subclass distribution of immunoglobulin G (IgG) to cytomegalovirus (CMV) in individuals from a number of clinical groups. Most CMV-seropositive individuals had IgG1 and IgG3. IgG2 and IgG4 were detected less frequently at very low levels of activity, mostly among mothers at delivery and renal patients. Most seroconversions were accompanied by an important increase of the IgG1 activity, whereas IgG3 appeared at lower levels; neither IgG2 nor IgG4 occurred. This suggests that these isotypes play a secondary role in the response to the CMV infection and that they may be considered markers of past infections. Anti-CMV IgG1 is the most efficiently transmitted through the placenta. Whether infected or not, newborns had the same subclass distribution and activity levels as their mothers. Isotype determination did not offer a decisive explanation of a number of discrepancies observed between CMV IgG enzyme-linked immunosorbent assay and complement fixation test results.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brubaker R. R. Mechanisms of bacterial virulence. Annu Rev Microbiol. 1985;39:21–50. doi: 10.1146/annurev.mi.39.100185.000321. [DOI] [PubMed] [Google Scholar]
  2. Hornsleth A., Bech-Thomsen N., Friis B. Detection by ELISA of IgG-subclass-specific antibodies in primary respiratory syncytial (RS) virus infections. J Med Virol. 1985 Aug;16(4):321–328. doi: 10.1002/jmv.1890160404. [DOI] [PubMed] [Google Scholar]
  3. Joassin L., Reginster M. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G. J Clin Microbiol. 1986 Mar;23(3):576–581. doi: 10.1128/jcm.23.3.576-581.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol. 1985 Dec;17(4):303–311. doi: 10.1002/jmv.1890170403. [DOI] [PubMed] [Google Scholar]
  5. Linde G. A., Hammarström L., Persson M. A., Smith C. I., Sundqvist V. A., Wahren B. Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun. 1983 Oct;42(1):237–244. doi: 10.1128/iai.42.1.237-244.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Linde G. A. Subclass distribution of rubella virus-specific immunoglobulin G. J Clin Microbiol. 1985 Jan;21(1):117–121. doi: 10.1128/jcm.21.1.117-121.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lowe J., Bird P., Hardie D., Jefferis R., Ling N. R. Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity. Immunology. 1982 Oct;47(2):329–336. [PMC free article] [PubMed] [Google Scholar]
  8. Middeldorp J. M., Jongsma J., ter Haar A., Schirm J., The T. H. Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J Clin Microbiol. 1984 Oct;20(4):763–771. doi: 10.1128/jcm.20.4.763-771.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Morell A., Roth-Wicky B., Skvaril F. Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect Immun. 1983 Feb;39(2):565–568. doi: 10.1128/iai.39.2.565-568.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rasmussen L., Kelsall D., Nelson R., Carney W., Hirsch M., Winston D., Preiksaitis J., Merigan T. C. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982 Feb;145(2):191–199. doi: 10.1093/infdis/145.2.191. [DOI] [PubMed] [Google Scholar]
  11. Ravaoarinoro M., Reginster M., Dormal A., Sondag-Thull D. Comparison between an enzyme linked immunosorbent assay and a complement fixation test in assessing the age-related acquisition of cytomegalovirus antibodies in groups of the population living in Belgium. Acta Clin Belg. 1984;39(1):6–12. doi: 10.1080/22953337.1984.11718974. [DOI] [PubMed] [Google Scholar]
  12. Reynolds D. W., Stagno S., Reynolds R., Alford C. A., Jr Perinatal cytomegalovirus infection: influence of placentally transferred maternal antibody. J Infect Dis. 1978 May;137(5):564–567. doi: 10.1093/infdis/137.5.564. [DOI] [PubMed] [Google Scholar]
  13. Robbins D. L., Wistar R., Jr Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis. J Rheumatol. 1985 Jun;12(3):437–443. [PubMed] [Google Scholar]
  14. Sundqvist V. A., Linde A., Wahren B. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol. 1984 Jul;20(1):94–98. doi: 10.1128/jcm.20.1.94-98.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sutherland S., Briggs J. D. The detection of antibodies to cytomegalovirus in the sera of renal transplant patients by an IgM antibody capture assay. J Med Virol. 1983;11(2):147–159. doi: 10.1002/jmv.1890110209. [DOI] [PubMed] [Google Scholar]
  16. Wagner D. K., Graham B. S., Wright P. F., Walsh E. E., Kim H. W., Reimer C. B., Nelson D. L., Chanock R. M., Murphy B. R. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol. 1986 Aug;24(2):304–306. doi: 10.1128/jcm.24.2.304-306.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Winston D. J., Ho W. G., Rasmussen L. E., Lin C. H., Chu H. L., Merigan T. C., Gale R. P. Use of intravenous immune globulin in patients receiving bone marrow transplants. J Clin Immunol. 1982 Apr;2(2 Suppl):42S–47S. doi: 10.1007/BF00918366. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES